0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pain Management Drugs Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-8R9452
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pain Management Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pain Management Drugs Market Research Report 2026

Code: QYRE-Auto-8R9452
Report
2026-01-23
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pain Management Drugs Market Size

The global Pain Management Drugs market was valued at US$ 38880 million in 2025 and is anticipated to reach US$ 48640 million by 2032, at a CAGR of 3.3% from 2026 to 2032.

Pain Management Drugs Market

Pain Management Drugs Market

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.
This report delivers a comprehensive overview of the global Pain Management Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pain Management Drugs. The Pain Management Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pain Management Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pain Management Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Pain Management Drugs Market Report

Report Metric Details
Report Name Pain Management Drugs Market
Accounted market size in 2025 US$ 38880 million
Forecasted market size in 2032 US$ 48640 million
CAGR 3.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Generic Opioids
  • Branded Opioids
  • NSAIDs
  • Others
Segment by Application
  • Hospitals
  • Drugstores
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo, Merck, Yunnan Baiyao, Teikoku Seiyaku, Teva, J&J, Assertio Therapeutics, Allergan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Pain Management Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Pain Management Drugs Market growing?

Ans: The Pain Management Drugs Market witnessing a CAGR of 3.3% during the forecast period 2026-2032.

What is the Pain Management Drugs Market size in 2032?

Ans: The Pain Management Drugs Market size in 2032 will be US$ 48640 million.

What is the GSK share in Pain Management Drugs Market?

Ans: The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019.

Who are the main players in the Pain Management Drugs Market report?

Ans: The main players in the Pain Management Drugs Market are GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo, Merck, Yunnan Baiyao, Teikoku Seiyaku, Teva, J&J, Assertio Therapeutics, Allergan

What are the Application segmentation covered in the Pain Management Drugs Market report?

Ans: The Applications covered in the Pain Management Drugs Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Pain Management Drugs Market report?

Ans: The Types covered in the Pain Management Drugs Market report are Generic Opioids, Branded Opioids, NSAIDs, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pain Management Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Generic Opioids
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pain Management Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pain Management Drugs Market Perspective (2021–2032)
2.2 Global Pain Management Drugs Growth Trends by Region
2.2.1 Global Pain Management Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pain Management Drugs Historic Market Size by Region (2021–2026)
2.2.3 Pain Management Drugs Forecasted Market Size by Region (2027–2032)
2.3 Pain Management Drugs Market Dynamics
2.3.1 Pain Management Drugs Industry Trends
2.3.2 Pain Management Drugs Market Drivers
2.3.3 Pain Management Drugs Market Challenges
2.3.4 Pain Management Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pain Management Drugs Players by Revenue
3.1.1 Global Top Pain Management Drugs Players by Revenue (2021–2026)
3.1.2 Global Pain Management Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Pain Management Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pain Management Drugs Revenue
3.4 Global Pain Management Drugs Market Concentration Ratio
3.4.1 Global Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pain Management Drugs Revenue in 2025
3.5 Global Key Players of Pain Management Drugs Head Offices and Areas Served
3.6 Global Key Players of Pain Management Drugs, Products and Applications
3.7 Global Key Players of Pain Management Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Pain Management Drugs Breakdown Data by Type
4.1 Global Pain Management Drugs Historic Market Size by Type (2021–2026)
4.2 Global Pain Management Drugs Forecasted Market Size by Type (2027–2032)
5 Pain Management Drugs Breakdown Data by Application
5.1 Global Pain Management Drugs Historic Market Size by Application (2021–2026)
5.2 Global Pain Management Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Pain Management Drugs Market Size (2021–2032)
6.2 North America Pain Management Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pain Management Drugs Market Size by Country (2021–2026)
6.4 North America Pain Management Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pain Management Drugs Market Size (2021–2032)
7.2 Europe Pain Management Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pain Management Drugs Market Size by Country (2021–2026)
7.4 Europe Pain Management Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pain Management Drugs Market Size (2021–2032)
8.2 Asia-Pacific Pain Management Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pain Management Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Pain Management Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pain Management Drugs Market Size (2021–2032)
9.2 Latin America Pain Management Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pain Management Drugs Market Size by Country (2021–2026)
9.4 Latin America Pain Management Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pain Management Drugs Market Size (2021–2032)
10.2 Middle East & Africa Pain Management Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pain Management Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Pain Management Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Pain Management Drugs Introduction
11.1.4 GSK Revenue in Pain Management Drugs Business (2021–2026)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Pain Management Drugs Introduction
11.2.4 Pfizer Revenue in Pain Management Drugs Business (2021–2026)
11.2.5 Pfizer Recent Development
11.3 Grunenthal
11.3.1 Grunenthal Company Details
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal Pain Management Drugs Introduction
11.3.4 Grunenthal Revenue in Pain Management Drugs Business (2021–2026)
11.3.5 Grunenthal Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Pain Management Drugs Introduction
11.4.4 Sanofi Revenue in Pain Management Drugs Business (2021–2026)
11.4.5 Sanofi Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Pain Management Drugs Introduction
11.5.4 Bayer Revenue in Pain Management Drugs Business (2021–2026)
11.5.5 Bayer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Pain Management Drugs Introduction
11.6.4 AstraZeneca Revenue in Pain Management Drugs Business (2021–2026)
11.6.5 AstraZeneca Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Pain Management Drugs Introduction
11.7.4 Eli Lilly Revenue in Pain Management Drugs Business (2021–2026)
11.7.5 Eli Lilly Recent Development
11.8 Endo
11.8.1 Endo Company Details
11.8.2 Endo Business Overview
11.8.3 Endo Pain Management Drugs Introduction
11.8.4 Endo Revenue in Pain Management Drugs Business (2021–2026)
11.8.5 Endo Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Pain Management Drugs Introduction
11.9.4 Merck Revenue in Pain Management Drugs Business (2021–2026)
11.9.5 Merck Recent Development
11.10 Yunnan Baiyao
11.10.1 Yunnan Baiyao Company Details
11.10.2 Yunnan Baiyao Business Overview
11.10.3 Yunnan Baiyao Pain Management Drugs Introduction
11.10.4 Yunnan Baiyao Revenue in Pain Management Drugs Business (2021–2026)
11.10.5 Yunnan Baiyao Recent Development
11.11 Teikoku Seiyaku
11.11.1 Teikoku Seiyaku Company Details
11.11.2 Teikoku Seiyaku Business Overview
11.11.3 Teikoku Seiyaku Pain Management Drugs Introduction
11.11.4 Teikoku Seiyaku Revenue in Pain Management Drugs Business (2021–2026)
11.11.5 Teikoku Seiyaku Recent Development
11.12 Teva
11.12.1 Teva Company Details
11.12.2 Teva Business Overview
11.12.3 Teva Pain Management Drugs Introduction
11.12.4 Teva Revenue in Pain Management Drugs Business (2021–2026)
11.12.5 Teva Recent Development
11.13 J&J
11.13.1 J&J Company Details
11.13.2 J&J Business Overview
11.13.3 J&J Pain Management Drugs Introduction
11.13.4 J&J Revenue in Pain Management Drugs Business (2021–2026)
11.13.5 J&J Recent Development
11.14 Assertio Therapeutics
11.14.1 Assertio Therapeutics Company Details
11.14.2 Assertio Therapeutics Business Overview
11.14.3 Assertio Therapeutics Pain Management Drugs Introduction
11.14.4 Assertio Therapeutics Revenue in Pain Management Drugs Business (2021–2026)
11.14.5 Assertio Therapeutics Recent Development
11.15 Allergan
11.15.1 Allergan Company Details
11.15.2 Allergan Business Overview
11.15.3 Allergan Pain Management Drugs Introduction
11.15.4 Allergan Revenue in Pain Management Drugs Business (2021–2026)
11.15.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pain Management Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Generic Opioids
 Table 3. Key Players of Branded Opioids
 Table 4. Key Players of NSAIDs
 Table 5. Key Players of Others
 Table 6. Global Pain Management Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Pain Management Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Pain Management Drugs Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Pain Management Drugs Market Share by Region (2021–2026)
 Table 10. Global Pain Management Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Pain Management Drugs Market Share by Region (2027–2032)
 Table 12. Pain Management Drugs Market Trends
 Table 13. Pain Management Drugs Market Drivers
 Table 14. Pain Management Drugs Market Challenges
 Table 15. Pain Management Drugs Market Restraints
 Table 16. Global Pain Management Drugs Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Pain Management Drugs Market Share by Players (2021–2026)
 Table 18. Global Top Pain Management Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pain Management Drugs Revenue, 2025
 Table 19. Ranking of Global Top Pain Management Drugs Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Pain Management Drugs Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Pain Management Drugs, Headquarters and Area Served
 Table 22. Global Key Players of Pain Management Drugs, Products and Applications
 Table 23. Global Key Players of Pain Management Drugs, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Pain Management Drugs Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Pain Management Drugs Revenue Market Share by Type (2021–2026)
 Table 27. Global Pain Management Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Pain Management Drugs Revenue Market Share by Type (2027–2032)
 Table 29. Global Pain Management Drugs Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Pain Management Drugs Revenue Market Share by Application (2021–2026)
 Table 31. Global Pain Management Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Pain Management Drugs Revenue Market Share by Application (2027–2032)
 Table 33. North America Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Pain Management Drugs Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Pain Management Drugs Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Pain Management Drugs Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Pain Management Drugs Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Pain Management Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Pain Management Drugs Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Pain Management Drugs Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Pain Management Drugs Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Pain Management Drugs Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Pain Management Drugs Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Pain Management Drugs Market Size by Country (US$ Million), 2027–2032
 Table 48. GSK Company Details
 Table 49. GSK Business Overview
 Table 50. GSK Pain Management Drugs Product
 Table 51. GSK Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 52. GSK Recent Development
 Table 53. Pfizer Company Details
 Table 54. Pfizer Business Overview
 Table 55. Pfizer Pain Management Drugs Product
 Table 56. Pfizer Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 57. Pfizer Recent Development
 Table 58. Grunenthal Company Details
 Table 59. Grunenthal Business Overview
 Table 60. Grunenthal Pain Management Drugs Product
 Table 61. Grunenthal Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 62. Grunenthal Recent Development
 Table 63. Sanofi Company Details
 Table 64. Sanofi Business Overview
 Table 65. Sanofi Pain Management Drugs Product
 Table 66. Sanofi Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 67. Sanofi Recent Development
 Table 68. Bayer Company Details
 Table 69. Bayer Business Overview
 Table 70. Bayer Pain Management Drugs Product
 Table 71. Bayer Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 72. Bayer Recent Development
 Table 73. AstraZeneca Company Details
 Table 74. AstraZeneca Business Overview
 Table 75. AstraZeneca Pain Management Drugs Product
 Table 76. AstraZeneca Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 77. AstraZeneca Recent Development
 Table 78. Eli Lilly Company Details
 Table 79. Eli Lilly Business Overview
 Table 80. Eli Lilly Pain Management Drugs Product
 Table 81. Eli Lilly Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 82. Eli Lilly Recent Development
 Table 83. Endo Company Details
 Table 84. Endo Business Overview
 Table 85. Endo Pain Management Drugs Product
 Table 86. Endo Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 87. Endo Recent Development
 Table 88. Merck Company Details
 Table 89. Merck Business Overview
 Table 90. Merck Pain Management Drugs Product
 Table 91. Merck Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 92. Merck Recent Development
 Table 93. Yunnan Baiyao Company Details
 Table 94. Yunnan Baiyao Business Overview
 Table 95. Yunnan Baiyao Pain Management Drugs Product
 Table 96. Yunnan Baiyao Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 97. Yunnan Baiyao Recent Development
 Table 98. Teikoku Seiyaku Company Details
 Table 99. Teikoku Seiyaku Business Overview
 Table 100. Teikoku Seiyaku Pain Management Drugs Product
 Table 101. Teikoku Seiyaku Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 102. Teikoku Seiyaku Recent Development
 Table 103. Teva Company Details
 Table 104. Teva Business Overview
 Table 105. Teva Pain Management Drugs Product
 Table 106. Teva Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 107. Teva Recent Development
 Table 108. J&J Company Details
 Table 109. J&J Business Overview
 Table 110. J&J Pain Management Drugs Product
 Table 111. J&J Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 112. J&J Recent Development
 Table 113. Assertio Therapeutics Company Details
 Table 114. Assertio Therapeutics Business Overview
 Table 115. Assertio Therapeutics Pain Management Drugs Product
 Table 116. Assertio Therapeutics Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 117. Assertio Therapeutics Recent Development
 Table 118. Allergan Company Details
 Table 119. Allergan Business Overview
 Table 120. Allergan Pain Management Drugs Product
 Table 121. Allergan Revenue in Pain Management Drugs Business (US$ Million), 2021–2026
 Table 122. Allergan Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Pain Management Drugs Picture
 Figure 2. Global Pain Management Drugs Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Pain Management Drugs Market Share by Type: 2025 vs 2032
 Figure 4. Generic Opioids Features
 Figure 5. Branded Opioids Features
 Figure 6. NSAIDs Features
 Figure 7. Others Features
 Figure 8. Global Pain Management Drugs Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Pain Management Drugs Market Share by Application: 2025 vs 2032
 Figure 10. Hospitals Case Studies
 Figure 11. Drugstores Case Studies
 Figure 12. Others Case Studies
 Figure 13. Pain Management Drugs Report Years Considered
 Figure 14. Global Pain Management Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Pain Management Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Pain Management Drugs Market Share by Region: 2025 vs 2032
 Figure 17. Global Pain Management Drugs Market Share by Players in 2025
 Figure 18. Global Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Pain Management Drugs Revenue in 2025
 Figure 20. North America Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Pain Management Drugs Market Share by Country (2021–2032)
 Figure 22. United States Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Pain Management Drugs Market Share by Country (2021–2032)
 Figure 26. Germany Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Pain Management Drugs Market Share by Region (2021–2032)
 Figure 34. China Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Pain Management Drugs Market Share by Country (2021–2032)
 Figure 42. Mexico Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Pain Management Drugs Market Share by Country (2021–2032)
 Figure 46. Israel Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Pain Management Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. GSK Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 50. Pfizer Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 51. Grunenthal Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 52. Sanofi Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 53. Bayer Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 54. AstraZeneca Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 55. Eli Lilly Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 56. Endo Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 57. Merck Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 58. Yunnan Baiyao Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 59. Teikoku Seiyaku Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 60. Teva Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 61. J&J Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 62. Assertio Therapeutics Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 63. Allergan Revenue Growth Rate in Pain Management Drugs Business (2021–2026)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String